BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18393403)

  • 1. Chemical genetics: exploring the role of the proteasome in cell biology using natural products and other small molecule proteasome inhibitors.
    Kim KB; Crews CM
    J Med Chem; 2008 May; 51(9):2600-5. PubMed ID: 18393403
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural compounds with proteasome inhibitory activity for cancer prevention and treatment.
    Yang H; Landis-Piwowar KR; Chen D; Milacic V; Dou QP
    Curr Protein Pept Sci; 2008 Jun; 9(3):227-39. PubMed ID: 18537678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-proteasome-inhibitory activity relationships of dietary flavonoids in human cancer cells.
    Chen D; Chen MS; Cui QC; Yang H; Dou QP
    Front Biosci; 2007 Jan; 12():1935-45. PubMed ID: 17127432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clogging the Ubiquitin-Proteasome Machinery with Marine Natural Products: Last Decade Update.
    Della Sala G; Agriesti F; Mazzoccoli C; Tataranni T; Costantino V; Piccoli C
    Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30486251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the proteasome pathway.
    Tsukamoto S; Yokosawa H
    Expert Opin Ther Targets; 2009 May; 13(5):605-21. PubMed ID: 19397479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kappaB with antimyeloma activity in vitro and in vivo.
    Tiedemann RE; Schmidt J; Keats JJ; Shi CX; Zhu YX; Palmer SE; Mao X; Schimmer AD; Stewart AK
    Blood; 2009 Apr; 113(17):4027-37. PubMed ID: 19096011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Natural Proteasome Inhibitors as Novel Anticancer Therapeutics: Current Status and Perspectives.
    Wang H; Yang Q; Dou QP; Yang H
    Curr Protein Pept Sci; 2018 Feb; 19(4):358-367. PubMed ID: 28079010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome inhibitors: recent advances and new perspectives in medicinal chemistry.
    Genin E; Reboud-Ravaux M; Vidal J
    Curr Top Med Chem; 2010; 10(3):232-56. PubMed ID: 20166955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Black tea polyphenols inhibit tumor proteasome activity.
    Mujtaba T; Dou QP
    In Vivo; 2012; 26(2):197-202. PubMed ID: 22351658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors.
    Zhu H; Zhang L; Dong F; Guo W; Wu S; Teraishi F; Davis JJ; Chiao PJ; Fang B
    Oncogene; 2005 Jul; 24(31):4993-9. PubMed ID: 15824729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome inhibitors induce death but activate NF-kappaB on endometrial carcinoma cell lines and primary culture explants.
    Dolcet X; Llobet D; Encinas M; Pallares J; Cabero A; Schoenenberger JA; Comella JX; Matias-Guiu X
    J Biol Chem; 2006 Aug; 281(31):22118-22130. PubMed ID: 16735506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome regulators: activators and inhibitors.
    Huang L; Chen CH
    Curr Med Chem; 2009; 16(8):931-9. PubMed ID: 19275603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy.
    Frezza M; Schmitt S; Dou QP
    Curr Top Med Chem; 2011 Dec; 11(23):2888-905. PubMed ID: 21824109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme inhibition by hydroamination: design and mechanism of a hybrid carmaphycin-syringolin enone proteasome inhibitor.
    Trivella DB; Pereira AR; Stein ML; Kasai Y; Byrum T; Valeriote FA; Tantillo DJ; Groll M; Gerwick WH; Moore BS
    Chem Biol; 2014 Jun; 21(6):782-91. PubMed ID: 24930969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells.
    Fribley A; Zeng Q; Wang CY
    Mol Cell Biol; 2004 Nov; 24(22):9695-704. PubMed ID: 15509775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural polyphenols properties: chemopreventive and chemosensitizing activities.
    Delmas D; Xiao J
    Anticancer Agents Med Chem; 2012 Oct; 12(8):835. PubMed ID: 22583400
    [No Abstract]   [Full Text] [Related]  

  • 17. Marizomib, a potent second generation proteasome inhibitor from natural origin.
    Ma L; Diao A
    Anticancer Agents Med Chem; 2015; 15(3):298-306. PubMed ID: 25403165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB.
    Dai Y; Desano J; Tang W; Meng X; Meng Y; Burstein E; Lawrence TS; Xu L
    PLoS One; 2010 Dec; 5(12):e14153. PubMed ID: 21170316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha.
    Place RF; Noonan EJ; Giardina C
    Biochem Pharmacol; 2005 Aug; 70(3):394-406. PubMed ID: 15950952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of nuclear factor-kappaB and proteasome by dithiocarbamate complexes with metals.
    Cvek B; Dvorak Z
    Curr Pharm Des; 2007; 13(30):3155-67. PubMed ID: 17979756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.